Submitted by Anonymous (not verified) on 12 December 2024 - 16:16
Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Date of authorisation: 18/09/2017, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Date of authorisation: 18/09/2017, Revision: 13, Status: Authorised